Matching-Adjusted Indirect Comparison of the Efficacy and Safety of Difamilast 1% and Delgocitinib 0.5% in Patients with Moderate-to-Severe Atopic Dermatitis

The anchored MAIC analysis indicates that difamilast treatment, like delgocitinib, is a useful option for the treatment of patients with moderate-to-severe AD in Japan.

Authors

Tomohiro Kondo
Miyuki Matsukawa
Hiroyuki Murota (ORCID: https://orcid.org/0000-0002-0450-1377)
Yilong Zhang (ORCID: https://orcid.org/0000-0001-6750-7613)
Takeshi Nakahara
Hiroe Takeda

Institutions

Otsuka (Japan) (JP)
Kyushu University (JP)
Otsuka Pharmaceutical (Spain) (ES)
Nagasaki University (JP)

Publication Details

Journal: Dermatology and Therapy
Published: 2024-10-01
DOI: https://doi.org/10.1007/s13555-024-01282-1
Citations: 1
Primary Topic: Dermatology and Skin Diseases
Type: article
Field-Weighted Citation Impact: 0.53

Funders

Otsuka Pharmaceutical

Controls

|||

ALL TIME

JAN

FEB

MAR

APR

MAY

JUN

JUL

AUG

SEP

OCT

article

Matching-Adjusted Indirect Comparison of the Efficacy and Safety of Difamilast 1% and Delgocitinib 0.5% in Patients with Moderate-to-Severe Atopic Dermatitis

Tomohiro Kondo, Miyuki Matsukawa, Hiroyuki Murota, Yilong Zhang et al.

Oct 1, 2024

1 citations

Dermatology and Therapy

Dermatology and Skin Diseases

0.53

article

Matching-Adjusted Indirect Comparison of the Efficacy and Safety of Difamilast 1% and Delgocitinib 0.5% in Patients with Moderate-to-Severe Atopic Dermatitis

Tomohiro Kondo, Miyuki Matsukawa, Hiroyuki Murota, Yilong Zhang, Takeshi Nakahara, Hiroe Takeda

October 1, 2024article en

1 citations

Abstract

The anchored MAIC analysis indicates that difamilast treatment, like delgocitinib, is a useful option for the treatment of patients with moderate-to-severe AD in Japan.

Dermatology and TherapyVol. 14(10)

Otsuka (Japan) (JP), Kyushu University (JP), Otsuka Pharmaceutical (Spain) (ES), Nagasaki University (JP)

Otsuka Pharmaceutical

Openalex Percentile: Top 28%

Dermatology and Skin Diseases

0.53

DOI Open Access PDF OpenAlex

AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Matching-Adjusted Indirect Comparison of the Efficacy and Safety of Difamilast 1% and Delgocitinib 0.5% in Patients with Moderate-to-Severe Atopic Dermatitis — Tomohiro Kondo, Miyuki Matsukawa, et al. · Dermatology and Therapy (2024) | TGRS Research Map | TGRS